Latest Conference Articles
Impact of HIV on Brain Structure and Function
March 10th 2021, 6:27pm
Deep learning models identified the largest differences in resting state network topology occurred.
Neutralizing Antibodies in SARS-CoV-2 Infected Children
March 10th 2021, 4:43pm
Plasma proteome confirmed the association between cellular and humoral SARS-CoV-2 immunity.
Proteomics May Identify Proteins Predictive of HIV Mortality
March 10th 2021, 2:48pm
The prognostic proteins identified can serve as the basis of future pathway and network analyses.
Findings for Extended Dapivrine Delivery Phase 1 Trial Reported
March 10th 2021, 1:41pm
Dapivrine (DPV) was studied in 1-month and 3-month durations.
COVID-19 and Viral Suppression
March 9th 2021, 10:47pm
During the pandemic, reduced HIV testing led to concerns about getting people diagnosed and on antiretroviral therapy (ART), and achieving viral suppression (VS).
Men Report Worse Respiratory, Inflammatory Status with SARS-CoV-2 than Women
March 9th 2021, 10:35pm
Johns Hopkins data suggest men are being hospitalized more frequently with infection, and are facing more severe outcomes.
Single Dose of mRNA Vaccine May be Enough for COVID-19 Experienced People
March 9th 2021, 9:19pm
MN titers showed a striking increase after just 1 dose in experienced subjects.
Using the MINMON Approach as a Safe and Simple Treatment for HCV
March 9th 2021, 7:32pm
COVID-19 has further highlighted the need for innovative models that minimize face-to-face contact in HCV treatment.
HIV Maturation Inhibitor Findings Presented
March 9th 2021, 7:00pm
ViiV Healthcare’s investigational therapy, GSK’254, demonstrated antiviral activity, safety, and tolerability in its phase 2a proof-of-concept findings.
Treating COVID-19 with Potent Neutralizing Antibodies
March 9th 2021, 6:00pm
Convalescent plasma treatment was found not to improve survival or disease course in the patient group.